Drugmaker Asks FDA , to Approve Over-The-Counter , Birth Control Pill.
On July 11, a French pharmaceutical company sought
regulatory approval to sell an over-the-counter
birth control pill in the United States.
NBC reports that HRA Pharma's application
comes amid legal and political battles
regarding women's reproductive health.
However, the company said the timing for
its application was unrelated to the Supreme Court's
recent decision to overturn Roe v. Wade.
According to NBC, hormone based birth
control has long been the most widely
used form of birth control in the U.S. .
Since the 1960s, birth control has required
a prescription and a medical screening for
conditions that raise the risk of blood clots.
The French drugmaker argues that years of research suggest that women can safely screen themselves for those conditions and use the pill effectively.
For a product that has been available
for the last 50 years, that has been
used safely by millions of women,
we thought it was time
to make it more available, Frederique Welgryn,
HRA’s chief strategy officer,
via 'The Guardian'.
NBC reports that FDA approval
could come as soon as next year. .
Reproductive rights advocates have reportedly been pushing for the approval of more over-the-counter contraceptives following the Roe v. Wade decision . .
Reproductive rights advocates have reportedly been pushing for the approval of more over-the-counter contraceptives following the Roe v. Wade decision . .
Now, the FDA likely faces intense political
scrutiny as it weighs a potentially
precedent-setting decision